D. Joseph Jerry

Professor; Science Director, Pioneer Valley Life Sciences Institute; Co-Director, Rays of Hope Center for Breast Cancer Research

Research areas include tumor suppressor genes and the cellular basis for susceptibility to breast cancer.

Current Research
The p53 tumor suppressor protein is a major focus of the laboratory because its genome surveillance activity can be enhanced by hormonal stimuli and it contributes to the protective effect of pregnancy. Although estrogen stimulates proliferation, it also potentiates the p53-mediated apoptosis. The estrogen receptor beta appears to be important in mediating the protective effects of estrogen. We have also shown that Activin, which is elevated during pregnancy, is a potent inhibitor of stem cells in the mouse and reduces the incidence of mammary tumors. The frequent mutation of p53 in breast cancer reflects its critical role. However, in mice bearing mutations in p53, the incidence of mammary tumors differs dramatically. Naturally-occurring variants in homology-directed DNA repair have revealed a profound role for this pathway in determining risk of mammary tumors. We are also determining gene expression profiles premalignant breast lesions. These studies provide the basis for diagnostic tests defining which patients are at high risk and should consider treatments while also providing insights into the molecular basis for premalignancy in the human breast.

Learn more at www.umass.edu/vasci/faculty/jerry/jerry.html

Academic Background

  • MS Purdue University
  • PhD The Pennsylvania State University
  • Postdoctoral training: Jackson Laboratory, Bar Harbor, Maine; Baylor College of Medicine, Houston, Texas
Jerry JD, Shull JD, Hadsell DL, Rijnkels M, Dunphy KA, Schneider SS, Vandenberg LN, Majhi PD, Byrne C, Trentham-Dietz A. 2018. Genetic variation in sensitivity to estrogens and breast cancer risk. Mammalian Genome. 29:24–37.
Schneider SS, Henchey EM, Sultana N, Morin SM, Jerry JD, Makari-Judson G, Crisi GM, Arenas RB, Johnson M, Mason HS et al.. 2017. Individual-specific variation in the respiratory activities of HMECs and their bioenergetic response to IGF1 and TNFa. Journal of Cellular Physiology. 232:2750–2765.
Le NDB, Tonga GY, Mout R, Kim S-T, Wille ME, Rana S, Dunphy KA, Jerry JD, Yazdani M, Ramanathan R et al.. 2017. Cancer Cell Discrimination Using Host–Guest “Doubled” Arrays. Journal of the American Chemical Society. 139:8008–8012.
Kundu N, Domingues CC, Chou C, Ahmadi N, Houston S, Jerry JD, Sen S. 2017. Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease. Journal of the American Heart Association. 6:e005146.
Mak P, Li J, Samanta S, Chang C, Jerry JD, Davis RJ, Leav I, Mercurio AM. 2015. Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression.. Cell Rep. 10(12):1982-91.
Sturgeon SR, Arcaro KF, Johnson MA, Balasubramanian R, Zorn M, Jerry JD, Schneider SS. 2014. DNA methylation in paired breast epithelial and white blood cells from women undergoing reduction mammoplasty.. Anticancer Res. 34(6):2985-90.
Rotunno M, Sun X, Figueroa J, Sherman ME, Garcia-Closas M, Meltzer P, Williams T, Schneider SS, Jerry JD, Yang XR et al.. 2014. Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status.. Breast Cancer Res. 16(4):R74.
Makari-Judson G, Braun B, Jerry JD, Mertens WC. 2014. Weight gain following breast cancer diagnosis: Implication and proposed mechanisms.. World J Clin Oncol. 5(3):272-82.
Contact Info

Department of Veterinary and Animal Sciences
427P Integrated Sciences Building
661 North Pleasant Street
Amherst, MA 01003-9292

(413) 545-5335